DX5+NKT cells induce the death of colitis-associated cells: Involvement of programmed death ligand-1

European Journal of Immunology

Volumn 36, Issue 5, 2006, Pages 1210-1221

  Hornung, Matthias ^a   Farkas, Stefan A ^a   Sattler, Christine ^a   Schlitt, Hans J ^a   Geissler, Edward K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

CD1d; Cell transfer; Colitis; DX5+NKT cells; Programmed death ligand 1

Indexed keywords

B7 ANTIGEN; CD1D ANTIGEN; DEXTRAN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PROGRAMMED DEATH LIGAND 1; SODIUM SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CHRONIC DISEASE; COLITIS; CONTROLLED STUDY; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN VITRO STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD1; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; COLITIS; KILLER CELLS, NATURAL; L-SELECTIN; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, SCID; PEPTIDES;

EID: 33646553070     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535332     Document Type: Article

References (52)

1. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 1993. 5: 1461-1471.
2. Bregenholt, S. and Claesson, M. H., Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur. J. Immunol. 1998. 28: 379-389.
3. + T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin. Exp. Immunol. 1996. 104: 491-500.
4. high T cells to SCID recipients. J. Immunol. 1997. 158: 3464-3473.
5. - T cells in mice and humans. J. Exp. Med. 1994. 180: 1097-1106.
6. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. and Van Kaer, L., NKT cells: what's in a name? Nat. Rev. Immunol. 2004. 4: 231-237.
7. - T cells. J. Exp. Med. 1997. 186: 109-120.
8. Bendelac, A., Rivera, M. N., Park S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
9. Burdin, N., Brossay, L, Degano, M., Iijima, H., Gui, M., Wilson, I. A. and Kronenberg, M., Structural requirements for antigen presentation by mouse CD1. Proc. Natl. Acad. Sci. USA 2000. 97: 10156-10161.
10. Kawano, T., Tanaka, Y., Shimizu, E., Kaneko, Y., Kamata, N., Sato, H., Osada, H. et al., A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int. Immunol. 1999. 11: 881-887
11. Joyce, S., Woods, A. S., Yewdell, J. W., Bennink, J. R., De Silva, A. D., Boesteanu, A., Balk, S. P. et al., Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998. 279: 1541-1544.
12. Burdin, N. and Kronenberg, M., CD1-mediated immune responses to glycolipids. Curr. Opin. Immunol. 1999. 11: 326-331.
13. Brigl, M. and Brenner, M. B., CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004. 22: 817-890.
14. Brossay, L., Jullien, D., Cardell, S., Sydora, B. C., Burdin, N., Modlin, R. L. and Kronenberg, M., Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 1997. 159: 1216-1224.
15. Sonmay-Wadgaonkar, K., Nusrat, A., Kim, H. S., Canchis, W. P., Balk, S. P., Colgan, S. P. and Blumberg, R. S., Immunolocalization of CDId in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol. 1999. 11: 383-392.
16. Benlagha, K. and Bendelac, A., CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity. Semin. Immunol. 2000. 12: 537-542.
17. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, L, Kaneko, Y. et al., Requirement for Valphal4 NKF cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
18. Saubermann, L. J., Beck, P., De Jong, Y. P., Pitman, R. S., Ryan, M. S., Kim, H. S., Exley, M. et al., Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 2000. 119: 119-128.
19. Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., Joyce, S. et al., Natural killer T cell activation protects mice against experimental autoimmune encephalomyelltis. J. Exp. Med 2001. 194: 1801-1811.
20. Jahng, A. W., Maricic, L, Pedersen, B., Burdin, N., Naidenko, O., Kronenberg, M., Koezuka, Y. and Kumar, V., Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 1789-1799.
21. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7; 1057-1062.
22. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
23. Sonoda, K. H., Taniguchi, M. and Stein-Streilein, J., Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J. Immunol. 2002. 168: 2028-2034.
24. Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S. and Strober, W., Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002. 17: 629-638.
25. + cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Bone Marrow Transplant. 2005. 35: 191-197.
26. Wirtz, S., Becker, C., Blumberg, R., Galle, P. R. and Neurath, M. F., Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 2002. 168: 411-420.
27. + T cells: insights into the regulatory role of interleukin-6 on apoptosis. Pathobiology 2002. 70: 170-176.
28. Farkas, S. A., Hornung, M., Sattler, C., Steinhauer, M., Anthuber, M., Obermeier, F., Herfarth, H. et al., Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis. Eur. Surg. Res. 2005. 37: 115-122.
29. Kajouharoff, G., Hans, W., Obermeier, F., Mannel, D. N., Andus, T., Scholmerich, J., Gross, V. and Falk W., Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 1997. 107: 353-358.
30. Wirtz, S. and Neurath, M. F., Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int. J. Colorectal Dis. 2000. 15: 144-160.
31. Chen, L., Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 2004. 4: 336-347.
32. Podolsky, D. K., Inflammatory bowel disease. N. Engl. J. Med. 2002. 347: 417-429.
33. Fiocchi, C., Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998. 115: 182-205.
34. Fiocchi, C., From immune activation to gut tissue injury: the pieces of the puzzle are coming together. Gastroenterology 1999. 117: 1238-1241.
35. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 1994. 179: 589-600.
36. Hollander, G. A., Simpson, S. J., Mizoguchi, E., Nichogiannopoulou, A., She, J., Gutierrez-Ramos, J. C., Blum, A. K. et al., Severe colitis in mice with aberrant thymic selection. Immunity 1995. 3: 27-38.
37. Page, M. J., Poritz, L. S., Tilberg, A. F., Zhang, W. J., Chorney, M. J. and Koltun, W. A., CD1d-restricted cellular lysis by peripheral blood lymphocytes: relevance to the inflammatory bowel diseases. J. Surg. Res. 2000. 92: 214-221.
38. Pellicci, D. G., Hammond, K. J., Coquet J., Kyparissoudis, K., Brooks, A. G., Kedzierska, K., Keating, R. et al., DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J. Immunol. 2005. 175: 4416-4425.
39. Yue, S. C., Shaulov, A., Wang, R., Balk S. P. and Exley, M. A., CD1d Ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12. Proc. Natl. Acad. Sci. USA 2005. 102: 11811-11816.
40. Colgan, S. P., Hershberg, R. M., Furuta, G. T. and Blumberg, R. S., Ligation of intestinal epithelial CD1d induces bioactive IL-1O: critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl. Acad. Sci. USA 1999. 96: 13938-13943.
41. De Libero, G. and Mori, L., Recognition of lipid antigens by T cells. Nat. Rev. Immunot. 2005. 5: 485-496.
42. Hava, D. L., Brigl, M., van den Elzen, P., Zajonc, D. M., Wilson, I. A. and Brenner, M. B., CD1 assembly and the formation of CD1-antigen complexes. Curr. Opin. Immunol. 2005. 17: 88-94.
43. Zhou, D., Mattner, J., Cantu, C. III, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKT cells. Science 2004. 306: 1786-1789.
44. Van Kaer, L. and Joyce, S., Innate immunity: NKT cells in the spotlight. Curr. Biol. 2005. 15: R429-R431.
45. Greenwald, R. J., Freeman, G. J. and Sharpe, A. H., The B7 family revisited. Annu. Rev. Immunol. 2005. 23: 515-548.
46. Kanai, T., Totsuka, T., Uraushihara, K., Makita, S., Nakamura, T., Koganei, K., Fukushima, T. et al., Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 2003. 171: 4156-4163.
47. Hornung, M., Lindemann, D., Kraus, C., Peters, A. and Berberich, I., The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest. Eur. J. Immunol. 1998. 28: 3812-3823.
48. Schofield, L., McConville, M. J., Hansen, D., Campbell, A. S., Fraser-Reid, B., Grusby, M. J. and Tachado, S. D., CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999. 283: 225-229.
49. Kawano, T., Cui, J., Koezuka, Y., Toura, L, Kaneko, Y., Motold, YL, Ueno, H. et al., CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
50. Obermeier, F., Dunger, N., Strauch, U. G., Grunwald, N., Herfarth, H., Scholmerich, J. and Falk, W., Contrasting activity of cytosine-guanosine dinucleotide oligonucleotides in mice with experimental colitis. Clin. Exp. Immunol. 2003. 134: 217-224.
51. Yamamoto, M., Fujihashi, K., Beagley, K. W., McGhee, J. R. and Kiyono, H., Cytokine synthesis by intestinal intraepithelial lymphocytes. Both gamma/delta T cell receptor-positive and alpha/beta T cell receptor-positive Tcells in the G1 phase of cell cycle produce IFN-gamma and IL-5. J. Immunol. 1993. 150: 106-114.
52. Overbergh, L, Valckx, D., Waer, M. and Mathieu, C., Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999. 11: 305-312.